一个随机的临床试验,研究使用数字干预来减少与妄想相关的激动
Michelle Nicholas1,2, Jessica Wittmann1, Monica Norena3
1Intensive Care Unit, Fraser Health Authority C/O Royal Columbian Hospital, New Westminster, BC, V3L 3W7, Canada.
NPJ digital medicine
|October 31, 2023
概括
一种新的数字治疗干预,MindfulGarden,显著减少了妄急性护理患者的激动. 这种以自然为基础的数字疗法为管理妄症状和减少药物需求提供了有希望的方法.
科学领域:
- 数字治疗学数字治疗学
- 急性护理药物急性护理药物
- 老年精神病学是一门精神病学专业.
背景情况:
- 痴呆症是急性护理环境中常见且严重的疾病,与增加的发病率和死亡率有关.
- 激动和非计划的药物使用是管理妄想患者的重大挑战,影响患者的福祉和医疗保健成本.
研究的目的:
- 评估一种新型数字治疗干预措施MindfulGarden在减轻成年狂妄患者激动的有效性.
- 评估干预措施对该群体非计划药物使用的影响.
主要方法:
- 一个随机对照试验,比较标准护理加上4小时接触MindfulGarden与单独标准护理.
- 参与者是成年人,在急性护理环境中经历过妄想.
- 使用里士满兴奋-镇静量表 (RASS) 测量了兴奋.
主要成果:
- 干预组在4小时的研究期间 (p=0.01) 与对照组 (0.9) 相比,RASS平均得分显著较低 (0.3).
- 数字干预证明了减少患者激动的好处.
结论:
- 暴露于基于自然的动态数字干预,MindfulGarden,有效地减少了狂妄急症患者的焦虑.
- 数字疗法代表了一个可行的,非药物治疗的选择,用于管理与妄想有关的激动.
更多相关视频
相关概念视频
Alzheimer's Disease: Treatment
200
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
200
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K


